These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7509088)

  • 21. Impact of screening blood donors for hepatitis C antibody on posttransfusion hepatitis: a prospective study with a second-generation anti-hepatitis C virus assay.
    Huang YY; Yang SS; Wu CH; Shih WS; Huang CS; Chen PH; Lin YM; Shen CT; Chen DS
    Transfusion; 1994 Aug; 34(8):661-5. PubMed ID: 7521077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence of anti-hepatitis C virus antibodies in non-A, non-B post-transfusion hepatitis in an area of northern Italy.
    Elia GF; Magnani G; Belli L; Formentini A; Iacono S; Marchelli S; Pincolini S; Lecchini R; Bernuzzi G; Fiaccadori F
    Infection; 1991; 19(5):336-9. PubMed ID: 1666064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Seroconversion to hepatitis C virus in dialysis patients: a retrospective and prospective study.
    Medin C; Allander T; Roll M; Jacobson SH; Grillner L
    Nephron; 1993; 65(1):40-5. PubMed ID: 7692314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic hepatitis C virus infection after treatment for pediatric malignancy.
    Cesaro S; Petris MG; Rossetti F; Cusinato R; Pipan C; Guido M; Masiero L; Botta GA; Meloni GA; Zanesco L
    Blood; 1997 Aug; 90(3):1315-20. PubMed ID: 9242567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Infectivity of blood seropositive for hepatitis C virus antibodies.
    van der Poel CL; Reesink HW; Schaasberg W; Leentvaar-Kuypers A; Bakker E; Exel-Oehlers PJ; Lelie PN
    Lancet; 1990 Mar; 335(8689):558-60. PubMed ID: 1968574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis.
    Alter HJ; Purcell RH; Shih JW; Melpolder JC; Houghton M; Choo QL; Kuo G
    N Engl J Med; 1989 Nov; 321(22):1494-500. PubMed ID: 2509915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis C virus infection is a risk factor for liver failure from veno-occlusive disease after bone marrow transplantation.
    Frickhofen N; Wiesneth M; Jainta C; Hertenstein B; Heymer B; Bianchi L; Dienes HP; Koerner K; Bunjes D; Arnold R
    Blood; 1994 Apr; 83(7):1998-2004. PubMed ID: 7511444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seroconversion to hepatitis C virus antibodies in patients with acute posttransfusion non-A, non-B hepatitis in Sweden.
    Mattsson L; Grillner L; von Sydow M; Bergdahl S; Weiland O
    Infection; 1991; 19(5):309-12. PubMed ID: 1666063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virus.
    Esteban JI; López-Talavera JC; Genescà J; Madoz P; Viladomiu L; Muñiz E; Martin-Vega C; Rosell M; Allende H; Vidal X
    Ann Intern Med; 1991 Sep; 115(6):443-9. PubMed ID: 1651674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors for cytomegalovirus, hepatitis B and C virus reactivation after bone marrow transplantation.
    Zekri AR; Mohamed WS; Samra MA; Sherif GM; El-Shehaby AM; El-Sayed MH
    Transpl Immunol; 2004 Dec; 13(4):305-11. PubMed ID: 15589744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of hepatitis C virus infection in multiply transfused premature neonates.
    Beeby PJ; Spencer JD; Cossart YE
    J Paediatr Child Health; 2001 Jun; 37(3):244-6. PubMed ID: 11468038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis C seroprevalence in bone marrow transplant recipients and haemophiliacs.
    Jackson SR; Carter JM; Jackson TW; Green GJ; Hawkins TE; Romeril K
    N Z Med J; 1994 Jan; 107(970):10-1. PubMed ID: 7507581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis.
    Esteban JI; González A; Hernández JM; Viladomiu L; Sánchez C; López-Talavera JC; Lucea D; Martin-Vega C; Vidal X; Esteban R
    N Engl J Med; 1990 Oct; 323(16):1107-12. PubMed ID: 2170839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis C virus infection in chronic haemodialysis patients, a clinicopathologic study.
    Alfurayh O; Sobh M; Buali A; Ali MA; Barri Y; Qunibi W; Taher S
    Nephrol Dial Transplant; 1992; 7(4):327-32. PubMed ID: 1375712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Infection of hepatitis C virus in patients with chronic renal failure undergoing hemodialysis therapy and staff members].
    Miyasaka M
    Nihon Jinzo Gakkai Shi; 1991 Oct; 33(10):989-99. PubMed ID: 1722830
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibodies to hepatitis C virus (HCV) and transaminase concentration in chronic haemodialysis patients: a study with second-generation assays.
    Fabrizi F; Raffaele L; Bacchini G; Guarnori I; Pontoriero G; Erba G; Locatelli F
    Nephrol Dial Transplant; 1993; 8(8):744-7. PubMed ID: 7692356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fulminant hepatitis is significantly increased in hepatitis B carriers after allogeneic bone marrow transplantation.
    Chen PM; Chiou TJ; Fan FS; Liu JM; Hsieh RK; Yen CC; Wang WS; Liu JH
    Transplantation; 1999 Jun; 67(11):1425-33. PubMed ID: 10385080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors and clinical expression of HCV infection in hemodialysis patients.
    Pauri P; Salvoni G; Vitolo W; Carletti P; Fanciulli E; Ricciatti AM; Della Bella S; Mioli VA
    Nephron; 1992; 61(3):313-4. PubMed ID: 1323778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Seroepidemiology of hepatitis C virus infection in Japan and HCV infection in haemodialysis patients.
    Yamaguchi K; Kiyokawa H; Machida J; Obayashi A; Nojiri N; Ueda S; Takatsuki K
    FEMS Microbiol Rev; 1994 Jul; 14(3):253-8. PubMed ID: 7522023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.